Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: J Pharmacokinet Pharmacodyn. 2012 May 26;39(4):313–327. doi: 10.1007/s10928-012-9252-6

Use of partition coefficients in flow-limited physiologically-based pharmacokinetic modeling

Matthew D Thompson 1, Daniel A Beard 2, Fan Wu 3
PMCID: PMC3400708  NIHMSID: NIHMS386449  PMID: 22639356

Abstract

Permeability-limited two-subcompartment and flow-limited, well-stirred tank tissue compartment models are routinely used in physiologically-based pharmacokinetic modeling. Here, the permeability-limited two-subcompartment model is used to derive a general flow-limited case of a two-subcompartment model with the well-stirred tank being a specific case where tissue fractional blood volume approaches zero. The general flow-limited two-subcompartment model provides a clear distinction between two partition coefficients typically used in PBPK: a biophysical partition coefficient and a well-stirred partition coefficient. Case studies using diazepam and cotinine demonstrate that, when the well-stirred tank is used with a priori predicted biophysical partition coefficients, simulations overestimate or underestimate total organ drug concentration relative to flow-limited two-subcompartment model behavior in tissues with higher fractional blood volumes. However, whole-body simulations show predicted drug concentrations in plasma and lower fractional blood volume tissues are relatively unaffected. These findings point to the importance of accurately determining tissue fractional blood volume for flow-limited PBPK modeling. Simulations using biophysical and well-stirred partition coefficients optimized with flow-limited two-subcompartment and well-stirred models, respectively, lead to nearly identical fits to tissue drug distribution data. Therefore, results of whole-body PBPK modeling with diazepam and cotinine indicate both flow-limited models are appropriate PBPK tissue models as long as the correct partition coefficient is used: the biophysical partition coefficient is for use with two-subcompartment models and the well-stirred partition coefficient is for use with the well-stirred tank model.

Keywords: Physiologically-based pharmacokinetics, Flow-limited, Permeability-limited, Well-stirred tank, Compartmental modeling, Partition coefficient, Biophysical, Diazepam, Cotinine

Introduction

Physiologically-based pharmacokinetic modeling has seen widespread use in toxicology and is emerging as an important tool in drug development [1]. The basic element of PBPK modeling is the tissue compartment model, and for over 30 years, the permeability-limited two-subcompartment model and its flow-limited counterpart, the well-stirred tank, have defined the field of PBPK. The permeability-limited two-subcompartment model has a sound mechanistic basis, as it can be derived [2] from the one-dimensional advection equation [3] assuming a lumped or spatially homogenized treatment of the vascular region. Therefore, in making comparisons of the different tissue compartment models, the permeability-limited two-subcompartment model is assumed to be the most biophysically realistic model that is required to simulate ADME processes operating on slower timescales. In the recent work of Thompson and Beard [2], the development of permeability-limited two-region asymptotically reduced and flow-limited two-region asymptotically reduced tissue compartment models afforded the opportunity to reevaluate the permeability-limited two-subcompartment and well-stirred tank models. Herein, this work is further extended by considering the permeability-limited two-subcompartment model in the limit of higher permeation relative to flow. A flow-limited two-subcompartment model is proposed that distinguishes two types of partition coefficients used in PBPK which are evaluated using pharmacokinetic data from the rat.

Methods: theoretical

Case I (definition): biophysical partition coefficient

Physicochemical properties of drugs are used to predict and/or constrain PBPK model parameters such as the partition coefficient [4,5]. The biophysical partitioning of a drug between the blood and tissues is determined in part by the thermodynamically-driven transfer of drug molecules between lipid and water phases [6]. To simplify and implement this biophysical partitioning in a PBPK tissue model, partitioning between the blood and tissue can be minimally represented by a two-compartment, well-mixed system at equilibrium. Therefore, the biophysical partition coefficient is defined from this equilibrium partitioning as

Pt:p=ctissuecplasma=c2c1 (1)

where ctissue is the concentration of drug in the tissue and cplasma is the concentration of drug in the plasma. This definition is most appropriately applied to a two-subcompartment, vascular:extravascular model where ctissue is the extravascular space, denoted by c2 in the model below, and where cplasma is the vascular space, denoted by c1 in the model. Advantageously, the biophysical partition coefficient is amenable to experimental measurement with techniques such as vial-equilibration methods [7] using tissue homogenates to determine partition coefficients for PBPK modeling [8]. In addition, algorithms have been developed based on drug physicochemical properties and tissue composition to generate a priori predicted partition coefficients for PBPK modeling applications [4,5,9]. Since the term tissue:plasma partition coefficient (Pt:p) is used by Poulin, et al. [4] when discussing a priori predicted values, the biophysical partition coefficient used herein is denoted as λbiophys and is meant to imply a predicted value for Pt:p, an in vitro measurement, or a value arrived at through fitting data with a two-subcompartment model.

Case I (model): two-subcompartment PBPK tissue model for use with the biophysical partition coefficient (λbiophys)

The biophysical partition coefficient used in PBPK modeling is most appropriately applied to the permeability-limited two-subcompartment model referred to as PLT by Thompson and Beard [2]. The permeability-limited two-subcompartment model is given by

dc1dt=QV1(cin-c1)-PSV1(c1-c2λbiophys) (2)

and

dc2dt=+PSV2(c1-c2λbiophys) (3)

where Q is flow, cin is the inflow concentration of drug, c1 is the concentration of drug in the vascular subcompartment, V1 is the vascular volume, c2 is the concentration of drug in the extravascular subcompartment, V2 is the extravascular volume, PS is the permeability-surface area product of the drug, and λbiophys is the partition coefficient of the drug relating c2 to c1 from Eq. 1.

Case II (definition): well-stirred partition coefficient

In 1984 [10], Rowland concisely discussed the issues of defining a steady-state partition coefficient for use in whole-body PBPK modeling and summarized the argument for the venous equilibrium partition coefficient as

Kp=cTcout (4)

where cT is the average concentration of drug in a single compartment model and the outflowing venous blood, cout, is at equilibrium with cT. Herein, this steady-state, well-stirred partition coefficient will be denoted as λwell-stirred.

Case II (model): single compartment well-stirred tank PBPK tissue model for use with the well-stirred partition coefficient (λwell-stirred)

The single compartment well-stirred tank is the default flow-limited tissue model used in PBPK applications unless physicochemical properties or pharmacokinetic time courses for tissue distribution indicate a possible permeability limitation [2]. The well-stirred tank (WST) model is governed by

dcTdt=QVT(cin-cTλwell-stirred) (5)

where Q is flow, cin is the inflow concentration of drug into the single compartment, cT is the average or overall concentration of the well-stirred compartment, VT is the total volume of the compartment, and λwell-stirred is the partition coefficient of drug at steady-state relating cT to cout from Eq. 4.

Use of well-stirred and biophysical partition coefficients

The biophysical and well-stirred partition coefficients are defined to varying degrees in the literature [1113], and the relationship between them is often unclear [5]. Failing to clearly distinguish well-stirred and biophysical partition coefficients leads to instances where the two definitions are used interchangeably between permeability-limited and flow-limited models [14,15], even though they imply and express different mathematical relationships between tissue and blood concentrations of drug based on the use of a two-subcompartment versus a single compartment tissue model.

Methods: flow-limited two-region model development

Recently, a PBPK tissue compartment modeling approach was developed by Thompson and Beard [2] that began to highlight this distinction. Using a singular perturbation analysis of the permeability-limited model (PLT), a new two-region asymptotically reduced model was developed that uses only one state variable. The permeability-limited two-region asymptotically reduced (P-TAR) model is given by

dc2dt=QV2(PS/Q1+PS/Q)(cin-c2λbiophys) (6)

and c1 is subsequently computed as

c1=cin+(PS/Q)(c2/λbiophys)1+PS/Q. (7)

In the flow-limiting case (PS/Q→∞), Eqs. 6 and 7 reduce to

dc2dt=QV2(cin-c2λbiophys) (8)

and

c1=c2λbiophys (9)

giving the flow-limited two-region asymptotically reduced (F-TAR) model. To conserve mass, the outflow concentration, cout, is computed using the dynamic mass balance equation

Q(cin-cout)=V1dc1dt+V2dc2dt (10)

to give cout for the permeability-limited two-region asymptotically reduced case as

cout=cin-1Q[V11+PS/Qdcindt+(V1PS/Q1+PS/Qλbiophys+V2)dc2dt] (11)

and cout for the flow-limited two-region asymptotically reduced case as

cout=(1+V1λbiophysV2)c2λbiophys-cinV1λbiophysV2. (12)

Further conditional statements are discussed and applied in Thompson and Beard [2]. Equations 6 through 12 allow drug concentration to be simulated in both vascular and extravascular regions by solving only one differential equation for either case.

To evaluate the permeability-limited two-region asymptotically reduced model and the flow-limited two-region asymptotically reduced model, comparisons were made to the standard permeability-limited two-subcompartment (PLT) (Eqs. 2,3) and well-stirred tank (WST) (Eq. 5) models. As shown in Thompson and Beard [2], the permeability-limited two-region asymptotically reduced (P-TAR) and flow-limited two-region asymptotically reduced (F-TAR) tissue models closely approximate the behavior of the permeability-limited two-subcompartment model and the permeability-limited two-subcompartment model in the limit of PS/Q→∞, respectively. However, from this analysis, the well-stirred tank model appeared to not be an appropriate choice when drugs differentially partition between the blood and tissue spaces [2]. Further theoretical analysis of 75 drugs with a range of a priori predicted partition coefficients evaluated in a set of 8 rat tissues and organs showed that use of the well-stirred tank model to simulate flow-limited transport in whole-body PBPK modeling can potentially result in large differences in model simulations compared to the flow-limited two-region asymptotically reduced model [16].

As a result of these studies, herein we develop a model to simulate the flow-limited extreme of the permeability-limited two-subcompartment model that is as accurate as and somewhat more convenient than the asymptotic approximation of the flow-limited two-region asymptotically reduced model. The flow-limited two-subcompartment model formulation, which provides a clear theoretical framework to implement the biophysical partition coefficient and distinguish it from the well-stirred partition coefficient, is described and evaluated below.

Methods: flow-limited two-subcompartment model development

Consider the total concentration of solute in a two-subcompartment system:

cT=V1c1+V2c2VT, (13)

where c1 and c2 are the concentrations of solute in the subcompartments, V1 and V2 are the volumes of the subcompartments, and VT = V1 + V2. Taking the time derivative,

dcTdt=V1VTdc1dt+V2VTdc2dt (14)

and substituting Eqs. 2 and 3, the governing equation for total concentration is

dcTdt=QVT(cin-c1). (15)

Assuming rapid equilibration between the vascular and extravascular spaces (c2= λbiophys c1), the outflow concentration (c1) is given by

cout=c1=cTFBV+(1-FBV)λbiophys, (16)

where FBV = V1/VT is the fractional blood volume of the compartment. Substituting into Eq. 15, we have

dcTdt=QVT(cin-cTFBV+(1-FBV)λbiophys). (17)

The flow-limited two-subcompartment model (Eq.17) can be re-expressed with

λwell-stirred=FBV+(1-FBV)λbiophys (18)

to simulate the same time courses as the well-stirred tank (Eq. 5). Figure 1a diagrams the flow-limited two-subcompartment model with rapid mixing and equilibration between the vascular and extravascular spaces. The well-stirred tank is obtained from the flow-limited two-subcompartment model in the limit of V1/VT→0 (Fig. 1b) where the FBV approaches zero and the outflow concentration of the flow-limited two-subcompartment model approaches the outflow concentration of the well-stirred tank model. Therefore, the well-stirred tank model is a specific flow-limited case of the permeability-limited two-subcompartment model.

Figure 1. Flow-limited two-subcompartment and well-stirred PBPK tissue compartment model diagrams.

Figure 1

A) Flow-limited two-subcompartment (FLT) model, Eq.17; and B) well-stirred tank (WST) model, Eq.5. The flow-limited two-subcompartment model has both vascular (V1) and extravascular (V2) spaces and simulates total concentration in the compartment, cT, as a function of the volume and concentrations in each subcompartment. The outflow concentration differs between the flow-limited two-subcompartment and well-stirred tank models depending on the type of partition coefficient used (λbiophys or λwell-stirred) and the fractional blood volume (FBV) of the compartment. The flow-limited two-subcompartment model is a general flow-limited case of the PLT model. The well-stirred tank model is a specific flow-limited case of the PLT model where FBV → 0.

In summary, we propose the following: 1) the flow-limited two-subcompartment model of Eq. 17 is the appropriate flow-limited counterpart to the permeability-limited two-subcompartment model for use in PBPK modeling when using the biophysical definition of the partition coefficient (λbiophys); 2) the well-stirred tank is an appropriate PBPK tissue model when using the well-stirred definition for the partition coefficient (λwell-stirred); and 3) the two partition coefficients, λbiophys and λwell-stirred, are related by a tissue’s fractional blood volume, assuming drug transport is flow-limited in a tissue with rapid equilibration between subcompartments.

Methods: PBPK tissue compartment model analysis

To demonstrate the effect of using a biophysical partition coefficient with the well-stirred tank, an open loop circulatory model [16] is used to simulate inflow concentration with

dcdosedt=-kacdose,dcindt=kacdose-kelcin, (19)

where ka (=0.001 sec−1) is the absorption rate constant, kel (=0.0005 sec−1) is the elimination rate constant, and cdose is set to 2 arbitrary units (a.u.) of concentration. A worst-case scenario is assessed using a model representing the human kidney. Physiological parameter values are from Brown, et al. [17]. The human kidney receives a mean flow distribution of cardiac output equal to 17.5%, or 1138 ml/min for a cardiac output of 6.5 l/min. For a 70 kg person, the kidney weight is 308 g (0.44% of the body weight) or 293 ml (kidney density of 1.05 g/ml). The fractional blood volume for the human kidney has been reported to be up to 50% [17] with a mean value of 36%. Simulations (Fig. 2) use a value of 50% for kidney fractional blood volume. Drug-specific parameters are λbiophys = 0.25 and 25, with the low and high values selected based on the range of λbiophys in 8 rat tissues and organs from a previous analysis of a priori predicted Pt:p for 75 structurally-unrelated drugs [16]. The λwell-stirred value is calculated based on Eq.18. Both Cmax and area under the curve (AUC) are assessed with the percent difference of the well-stirred model (using λbiophys) expressed relative to the flow-limited two-subcompartment model (using the same λbiophys).

Figure 2. Flow-limited model simulations using a biophysical partition coefficient in a model representing the human kidney: a worst-case scenario.

Figure 2

A,B) Well-stirred tank with λbiophys (solid black lines, indicated by black arrowheads), well-stirred tank with λwell-stirred (solid light gray lines); flow-limited two-subcompartment with λbiophys (dashed black lines). Simulations are based on Eq.19 with ka = 0.001 sec−1 and kel = 0.0005 sec−1; physiological parameters: VT = 293 ml, FBV = 0.5, Q = 1138 ml · min−1; drug-specific parameter: A) λbiophys = 0.25 with λwell-stirred calculated based on Eq.18; B) λbiophys = 25 with λwell-stirred calculated based on Eq.18. Arbitrary units (a.u.) of concentration are plotted versus time in hours. Insets show overlapping peak concentration-time curves for the well-stirred tank model with λwell-stirred and the flow-limited two-subcompartment model with λbiophys.

Though this set of simulations shows how model agreement depends on the partition coefficient definition used, evaluation of rat pharmacokinetic data for two drugs, diazepam and cotinine, provides an opportunity to study PBPK tissue model behavior in a whole-body context.

Methods: case study of diazepam (λ>1) in the rat

Diazepam is a well-studied benzodiazepine with several tissue distribution studies in the literature [1821] forming the basis of diazepam PBPK modeling papers on optimization [18,22], fuzzy simulation [19,23], and Bayesian approaches [20]. The PBPK model structure (Fig. 3) proposed for diazepam analysis [20] is used herein to evaluate the new flow-limited two-subcompartment model (using λbiophys) compared to the well-stirred tank (using λbiophys and λwell-stirred). The physicochemical properties of diazepam (logP value of 2.99 [5] and an unbound fraction (fu) in the plasma of 0.15 [19]), result in predicted partition coefficients greater than 1 for all tissues (Table 2) based on the method of Poulin, et al. [4,5] with the correction by Berezhkovskiy [24]. The ratio of blood to plasma diazepam is set equal to 1 [18]. Tissue time course data for diazepam in the rat (1 mg/kg, intravenous infusion) are from the work of Gueorguieva et al. [20]. Rat tissue blood flows and tissue masses are obtained from Gueorguieva, et al. [20] and can be found in Table 1. Fractional blood volume (FBV) is obtained from the work of Everett, et al. [25] or Brown, et al. [17], with values given for both the mean and range of fractional blood volume when available, as indicated in Table 1. Values for the human [17,20] are also provided in Table 1 for reference.

Figure 3. PBPK model structure.

Figure 3

Diazepam PBPK model structure has 12 tissue compartments and 2 blood compartments (arterial side and venous side of circulation) as implemented by Gueorguieva et al. [19]. Cotinine simulations use the same model structure.

Table 2.

Partition coefficients and clearance for diazepam case study

Tissue FBVa Partition Coefficients for Diazepamb

λapriori λbiophys λwell-stirred

Adipose 0.02 15.2 23.1 23.1
Brain 0.03 7.1 2.2 2.2
Heart 0.26 2.5 5.4 4.3
Kidney 0.16 2.9 5.7 5.2
Liver 0.21 3.1 9.7 9.1
Lung 0.36 3.5 7.3 5.3
Muscle 0.04 1.9 2.5 2.4
Remainderc 0.05 4.9 16.0 16.5
Skin 0.02 3.9 3.1 3.2
Splanchnic 0.035 4.4 4.1 4.3
Stomach 0.035 4.9 4.5 4.5
Testes 0.017 4.9 4.6 4.7

CLINT (ml/min)
Clearance 83d 374e 422e
a

Mean rat fractional blood volumes (FBV) from Table I

b

λapriori is the a priori predicted tissue:plasma partition coefficients for diazepam estimated using the method of Poulin et al. [4] with the correction by Berezhkovskiy [24]; λbiophys is the biophysical partition coefficient between the two subcompartments; λwell-stirred is the well-stirred partition coefficient of the single compartment well-stirred tank; the partition coefficients, λbiophys and λwell-stirred, are determined via optimization

c

Stomach and testes compartments are given the same λapriori partition coefficient values as the remainder (λapriori = 4.9)

d

Predicted intrinsic clearance from Poulin, et al. [5]

e

Optimized intrinsic clearance value corresponding to each given set of optimized partition coefficients

Table 1.

Physiological parameter values for a 250 g rat

Tissue Rata Fractional Blood Volumeb (FBV)
Flow Weight

ml/min g mean range
Adipose 2.55 10 0.02(h) 0.02–0.03(h)
Brain 0.78 1.2 0.03(r), 0.04(h) 0.02–0.04(r), 0.03–0.1(h)
Heart 4.2 1 0.26(r) -
Kidney 16.61 2 0.16(r), 0.36(h) 0.11–0.27(r), 0.22–0.5(h)
Liver 3.55 11 0.21(r), 0.11(h) 0.12–0.27(r)
Lung 80 1.2 0.36(r) 0.26–0.52(r)
Muscle 16.25 125 0.04(r), 0.01(h) 0.01–0.09(r)
Skin 7.1 43.8 0.02(r), 0.08(h) -
Splanchnic 20.25 15 0.035(r)c -
Stomach 1.9 1.1 0.035(r) c -
Testes 1.9 2.5 0.017(r) c -
Remainder 4.91 15.8 0.05d -
Venous 80 13.6 - -
Arterial 80 6.8 - -
Whole Body 80 250 - -
a

Gueorguiev a, et al. [20]

b

Brown, et al. [17], r-rat, h-human

c

estimated from Everett, et al. [25], r-rat

d

assumed

The well-stirred tank model equations governing liver metabolism of diazepam are based on Gueorguieva et al. [20]. Herein, the equations for the well-stirred model are presented as

Inflowliver=Qhepaticcin,arterial+Qstomachcout,stomach+Qsplanchniccout,splanchnic (20)
Qliver=Qhepatic+Qstomach+Qsplanchnic (21)
VliverdcT,liverd=Inflowliver-QlivercT,liverλwell-stirred-CLINTcT,liverλwell-stirred/fub (22)

where R is the blood to plasma ratio, fu is the unbound fraction in plasma, fub = fu/R, and CLINT is the intrinsic clearance. Liver blood flow (Qliver) is the sum of hepatic artery blood flow (Qhepatic), stomach blood flow (Qstomach), and splanchnic blood flow (Qsplanchnic). The governing equation for liver metabolism of diazepam for the flow-limited two-subcompartment liver tissue model is given by

VliverdcT,liverdt=Inflowliver-QlivercT,liverFBV+(1-FBV)λbiophys-CLINTcT,liver[FBV+(1-FBV)λbiophys]/fub, (23)

with Eq. 23 reducing to Eq. 22 when FBV approaches zero or λbiophys = 1.

Methods: case study of cotinine (λ<1) in the rat

Cotinine is a polar metabolite of nicotine that has been used as a biomarker for smoking exposure [26] with previous PBPK modeling indicating cotinine has flow-limited distribution to tissues in the rat [27]. Cotinine is predicted to have partition coefficients less than 1 for all tissues (Table 4) based on the method of Poulin, et al. [4] with the correction by Berezhkovskiy [24]. The ratio of blood to plasma cotinine is equal to 0.88 [28]. Physicochemical properties of cotinine include a logP value of −0.3 [29] and an unbound fraction (fu) in the plasma of 0.97 [4].

Table 4.

Partition coefficients and clearance for cotinine case study

Tissue FBVa Partition Coefficients for Cotinineb

λapriori λbiophysc λwell-stirredd

Adipose 0.02 0.61 0.02 0.04
Brain 0.03 0.87 0.25 0.27
Heart 0.26 0.82 0.03 0.28
Kidney 0.16 0.82 0.67 0.72
Liver 0.21 0.76 0.23 0.39
Lung 0.36 0.83 0.001* 0.30
Muscle 0.04 0.79 0.26 0.29
Remaindere 0.05 0.78 0.14 0.18
Splanchnic 0.035 0.79 0.28 0.31

CLINT (ml/min)
Clearance 0.21 0.13f 0.13g
a

Mean rat fractional blood volumes (FBV) from Table I

b

λapriori is the a priori predicted tissue:plasma partition coefficients for cotinine estimated using the method of Poulin et al. [4] with the correction by Berezhkovskiy [24]; λbiophys is the biophysical partition coefficient between the two subcompartments; λwell-stirred is the well-stirred partition coefficient of the single compartment well-stirred tank.

c

The λbiophys partition coefficients are calculated from optimized λwell-stirred values using Eq.18 with the partition coefficient for lung being set arbitrarily low (indicated by *)

d

The λwell-stirred partition coefficients are determined via optimization

e

Skin, stomach, and testes were kept as compartments in the model but were given the same respective partition coefficient value as the remainder (λapriori = 0.78, λbiophys = 0.14, or λwell-stirred = 0.18)

f

Well-stirred tank-optimized intrinsic clearance value is used in flow-limited two-subcompartment simulations

g

Well-stirred tank-optimized intrinsic clearance value

Tissue time course data for cotinine (0.5 mg, intravenous bolus) in the rat are obtained from the published work of Gabrielsson, et al. [27], digitized (ScanIt V1.04, AmsterCHEM, Almeria, Spain), and analyzed with the same model structure used for diazepam (Fig. 3). Based on the tissues reported [27], the level of detail in the PBPK model structure is preserved without lumping; however, the values for partition coefficients used for the skin, stomach, and testes are assumed to be the same as the remainder compartment, both during optimization as well as simulation with a priori predicted values (Table 4).

All simulations and optimization using Monte Carlo and fmincon approaches are carried out in Matlab v.R2010a, (Mathworks, Natick, MA).

Results and Discussion

Comparing models using biophysical and well-stirred partition coefficients

As shown previously [2], the permeability-limited two-region asymptotically reduced model closely follows permeability-limited two-subcompartment model behavior and the flow-limited two-region asymptotically reduced model closely follows a numerically-approximated (PS/Q→∞), flow-limited version of the permeability-limited two-subcompartment model. Neither the numerically-approximated flow-limited version of the permeability-limited two-subcompartment model nor the flow-limited two-region asymptotically reduced model agreed with the well-stirred tank model except at values of λ = 1 [2,16]. To further investigate this issue, a general flow-limited case of the permeability-limited two-subcompartment model, the flow-limited two-subcompartment tissue compartment model, is developed herein, with the well-stirred tank model being a specific case of the flow-limited two-subcompartment model where V1/VT→0. The hierarchy of tissue models (the permeability-limited two-subcompartment leading to the flow-limited two-subcompartment leading to the well-stirred tank) demonstrates that all of the tissue models are biophysically appropriate; however, the models differ regarding the interpretation of the partition coefficient.

Simulations show that the flow-limited two-subcompartment model agrees well with the numerically-approximated, flow-limited version of the permeability-limited two-subcompartment model, as well as the flow-limited two-region asymptotically reduced model regardless of the value of the λbiophys partition coefficient. However, when the same partition coefficient, λbiophys, is used in the well-stirred tank model, the well-stirred tank overestimates cT (Fig. 2B, solid black line indicated by black arrowhead) when λbiophys is greater than 1 and underestimates cT (Fig. 2A, solid black line indicated by black arrowhead) when λbiophys is less than 1. The worst-case result of not correcting a priori predicted partition coefficients prior to use in the well-stirred tank model is explored with an open circulatory loop approach, here using physiological parameters for the human kidney. Both the peak concentration (Cmax) and area under the curve (AUC) substantially differ between well-stirred tank and flow-limited two-subcompartment model simulations. Well-stirred tank Cmax percent difference ranges from −60% to +86% and well-stirred tank AUC percent difference ranges from -60% to +103% (when λbiophys is set to 0.25 and 25, respectively). If the λbiophys value used with the well-stirred tank is adjusted according to Eq. 18, the well-stirred simulations (Fig. 2A,B; solid light gray lines) match flow-limited two-subcompartment simulations (Fig. 2A,B; dashed black lines).

Tissues and organs, such as the skin, brain, adipose, and skeletal muscle have relatively small fractional blood volumes and the differences will be substantially less [16]. However, spleen, heart, lung, and tissues and organs that play key roles in ADME processes, such as liver and kidney, have higher fractional blood volumes [17] that may impact estimation of metabolic clearance or elimination rates (rat FBV range: liver [0.12–0.27], lung [0.26–0.52], kidney [0.11–0.27]; human FBV range: kidney [0.22–0.50]). Thus theoretically, proper matching of a flow-limited model with a partition coefficient is important. However, whole-body analysis of pharmacokinetic data is needed to evaluate these theoretical considerations.

Diazepam case study: pharmacokinetics in the rat

Simulations using a priori predicted partition coefficients for diazepam

Since the well-stirred tank is a reasonable approximation of the flow-limited two-subcompartment model when tissue fractional blood volume is low (adipose, brain, muscle, skin, splanchnic, stomach, and testes), well-stirred simulations (Fig. 4; solid black lines) are very close to flow-limited two-subcompartment simulations (Fig. 4; dashed gray lines). Area under the curve values are listed by tissue in Table 3. The percent difference for these tissues averages −2.7% (range of −1.9% to −3.6%). Simulations of plasma concentration of diazepam also show well-stirred tank simulations (Fig. 4; solid black lines) being nearly identical to flow-limited two-subcompartment simulations (Fig. 4; dashed gray lines). This observation implies that selection of an inappropriate partition coefficient for use with the well-stirred tank PBPK tissue model has minimal impact on the systemic kinetics of plasma diazepam (Table 3, area under the curve). This finding may be partly explained by the PBPK model structure used herein, where approximately 87% of tissue mass has a fractional blood volume of less than or equal to 0.05. Counter to findings in low fractional blood volume tissues and the plasma, tissues and organs with higher fractional blood volumes, plotted in Fig. 4 (heart, kidney, liver, lung), do differ more when a priori values are used with both models. Area under the curve values (Table 3) for these organs differ by an average of −21.3% (range of −12.5% to −35.7%). Also, in the tissues with higher fractional blood volume, the flow-limited two-subcompartment model simulations using a priori predicted partition coefficients are closer to the experimental data, indicating that consideration of fractional blood volume by the flow-limited two-compartment model may improve model prediction for diazepam.

Figure 4. Simulated concentration-time curves using a priori predicted partition coefficients for diazepam.

Figure 4

Plasma, adipose, brain, heart, kidney, liver, lung, muscle, skin, splanchnic, stomach, and testes concentration-time curves are simulated using a priori predicted partition coefficients based on the method of Poulin et al. [4] with the correction by Berezhkovskiy [24]. Well-stirred tank (solid black lines) and flow-limited two-subcompartment (dashed gray lines) model simulations are plotted against pharmacokinetic data (open circles) in the rat from Gueorguieva et al. [20]. Diazepam partition coefficient values are reported in Table 2, and AUC values are reported in Table 3.

Table 3.

Area under the curve (AUC) for diazepam simulations with the flow-limited two-subcompartment and well-stirred tank models

Tissue AUC for Diazepama
FLT (λapriori)b (×1010) WST (λapriori)c (×1010) %diffd FLT-opt (λbiophys)e (×1010) WST-opt (λwell-stirred)f (×1010) %diffg

Adipose 14.0 14.3 −1.9 9.90 9.70 2.1
Brain 4.93 5.09 −3.4 0.50 0.48 3.2
Heart 1.35 1.61 −19.3 0.94 0.92 2.5
Kidney 1.66 1.86 −12.5 1.10 1.08 1.5
Liver 1.19 1.40 −17.6 0.58 0.59 −1.9
Lung 1.67 2.26 −35.7 1.09 1.09 0.2
Muscle 1.39 1.42 −2.6 0.71 0.68 3.7
Remainder 3.55 3.73 −5.1 6.02 6.37 −5.9
Skin 3.05 3.11 −2.0 0.92 0.91 0.6
Splanchnic 2.83 2.93 −3.5 0.91 0.95 −4.0
Stomach 3.16 3.27 −3.6 1.00 0.98 2.6
Testes 3.34 3.41 −2.0 1.10 1.08 1.5
Plasma (art)h 0.64 0.64 −0.7 0.22 0.21 5.0
Plasma (ven)h 0.64 0.64 −0.6 0.22 0.21 5.0
a

Area under the curve (AUC) for time courses plotted in Figs. 4 and 5.

b

AUC values based on using diazepam λapriori values in the flow-limited two-subcompartment (FLT) model

c

AUC values based on using diazepam λapriori values in the well-stirred tank model (WST)

d

Percent difference in AUC between FLT and WST models using λapriori calculated as [(AUCFLT − AUCWST)/AUCFLT]×100

e

AUC values based on using diazepam λbiophys optimized with the flow-limited two-subcompartment model

f

AUC values based on using diazepam λwell-stirred optimized with the well-stirred tank model

g

Percent difference in AUC between FLT and WST models using optimized partition coefficients calculated as [(AUCFLT − AUCWST)/AUCFLT]×100

h

Arterial compartment (art) and venous compartment (ven)

Optimization of diazepam partition coefficients and clearance parameters with well-stirred tank and flow-limited two-subcompartment models

Partition coefficients optimized using the well-stirred tank model differ from coefficients optimized using the flow-limited two-subcompartment model in a predictable manner (Table 2). Higher fractional blood volume organs (heart, 20.4%; lung, 27.4%) differ the most in optimized partition coefficient values. Simulations using the optimized values (Fig. 5; well-stirred simulation, solid black line; flow-limited two-subcompartment, dashed gray line) and area under the curve data (Table 3) show the models produce similar results, including simulation of diazepam plasma concentration. Therefore, for drugs with partition coefficients greater than 1, optimization with either the flow-limited two-subcompartment model (using λbiophys) or with the well-stirred tank (using λwell-stirred) produce similar fits to experimental data.

Figure 5. Simulated concentration-time curves using well-stirred and flow-limited two-subcompartment model-optimized partition coefficients for diazepam.

Figure 5

Lower fractional blood volume tissues (adipose, brain, muscle, skin, splanchnic, stomach, and testes), higher fractional blood volume tissues (heart, kidney, liver, lung), and plasma concentration-time curves are simulated using optimized partition coefficients. The well-stirred model is used to optimize diazepam well-stirred partition coefficients, and the flow-limited two-subcompartment model is used to optimize diazepam biophysical partition coefficients (Table 2). Well-stirred tank (solid black lines) and flow-limited two-subcompartment (dashed gray lines) model simulations are plotted against pharmacokinetic data (open circles) in the rat from Gueorguieva et al. [20]. AUC values are reported in Table 3.

Cotinine case study: pharmacokinetics in the rat

Simulations using a priori predicted partition coefficients for cotinine

Similar to findings for diazepam, well-stirred tank simulations (Fig. 6; solid medium gray lines) are very close to flow-limited two-subcompartment simulations (Fig. 6; dashed dark gray lines) for low fractional blood volume tissues. However, simulations for tissues with higher fractional blood volumes are also similar because the a priori predicted coefficients are relatively close to 1 (Table 4, cotinine partition coefficients). The AUC percent difference for tissues averages 3.4% (range of 0.9% to 7.3%). Simulations of plasma concentration of cotinine are even closer (0.5%, Table 5), again showing that use of a biophysical partition coefficient in the well-stirred tank model has minimal impact on the systemic kinetics of plasma cotinine. However, fits of a priori based simulations to the experimental data are poor, as a priori prediction overestimated the values for the tissue partition coefficients. This leads to larger uptake by tissues and lower plasma concentrations than observed in the rat pharmacokinetic study. As seen in Table 4, the difference between a priori values and either biophysical or well-stirred coefficients is greater than the difference between the biophysical and well-stirred partition coefficients. As a result, a priori predicted values for cotinine do not provide a reference point to which flow-limited two-subcompartment optimized partition coefficients can readily be compared. This result is not entirely unexpected as Rodgers, et al. noted that methods to predict partition coefficients are considered reasonably accurate if within a factor of 3 of the experimentally determined values [30].

Figure 6. Simulated concentration-time curves using a priori predicted partition coefficients for cotinine.

Figure 6

Adipose, brain, heart, kidney, liver, lung, muscle, and splanchnic concentration-time curves are simulated using a priori predicted partition coefficients based on the method of Poulin et al. [4] with the correction by Berezhkovskiy [24]. Well-stirred tank (solid medium gray lines) and flow-limited two-subcompartment (dashed dark gray lines) model simulations are plotted against rat pharmacokinetic data from Gabrielsson, et al. [27] (filled dark gray circles, mean; vertical bars, range). Plasma concentration-time curves are also plotted in each tissue panel (well-stirred, solid light gray lines; flow-limited two-subcompartment, dashed medium gray lines) against rat plasma time course data (filled light gray squares, mean; vertical bars, range). Partition coefficient values for cotinine are reported in Table 4, and AUC values are reported in Table 5.

Table 5.

Area under the curve (AUC) for cotinine simulations with the flow-limited two-subcompartment and well-stirred tank models

Tissue AUC for Cotininea
FLT (λapriori)b (×1011) WST (λapriori)c (×1011) %diffd FLT-calc (λbiophys)e (×1011) WST-opt (λwell-stirred)f (×1011) %diffg

Adipose 3.31 3.25 1.7 0.23 0.23 −0.1
Brain 4.68 4.63 0.9 1.77 1.77 −0.1
Heart 4.63 4.36 5.8 1.85 1.86 −0.1
Kidney 4.53 4.36 3.8 4.76 4.76 −0.1
Liver 4.29 4.01 6.7 2.56 2.57 −0.1
Lung 4.76 4.41 7.3 2.37 2.00 15.7
Muscle 4.29 4.23 1.5 1.89 1.89 −0.1
Remainder 4.24 4.16 1.8 1.21 1.21 −0.1
Splanchnic 4.26 4.20 1.4 2.03 2.04 −0.1
Plasma (art)h 5.34 5.32 0.5 6.58 6.59 −0.1
Plasma (ven)h 5.34 5.32 0.5 6.58 6.59 −0.1
a

Area under the curve (AUC) for time courses plotted in Figs. 6 and 7.

b

AUC values based on using cotinine λapriori values in the flow-limited two-subcompartment model (FLT)

c

AUC values based on using cotinine λapriori values in the well-stirred tank model (WST)

d

Percent difference in AUC between FLT and WST models using λapriori calculated as [(AUCFLT − AUCWST)/AUCFLT]×100

e

AUC values based on using calculated cotinine λbiophys (calculated from optimized λwell-stirred values using Eq.18)

f

AUC values based on using optimized cotinine λwell-stirred (optimized with the well-stirred tank model)

g

Percent difference in AUC between FLT and WST models calculated as [(AUCFLT − AUCWST)/AUCFLT]×100

h

Arterial compartment (art) and venous compartment (ven)

Optimization of cotinine well-stirred partition coefficients using the well-stirred tank model and translation of well-stirred partition coefficients to biophysical partition coefficients

In contrast to the case study of diazepam, only the well-stirred partition coefficients are optimized for cotinine. The optimized well-stirred partition coefficients are then adjusted based on Eq.18 to give the biophysical partition coefficients for the flow-limited two subcompartment model simulations, with the clearance parameter kept the same between the models (Table 4). In this situation, well-stirred simulations (Fig. 7; solid light gray lines) are nearly identical to flow-limited two-subcompartment simulations (Fig. 7; dashed dark gray lines) in all tissues (Table 5, AUC percent difference) with one exception. The optimized well-stirred partition coefficient for cotinine in the lung is lower than the fractional blood volume for the lung. The relationship between λwell-stirred and λbiophys, as described by Eq. 18, yields a value for λbiophys that would be negative. Since a negative concentration ratio is not reasonable in PBPK, an arbitrarily low value for λbiophys is used in the simulation. As seen in Fig. 7, the flow-limited two-subcompartment model (dashed dark gray line) cannot fit the lung data, unlike the well-stirred tank (solid light gray line). This finding implies either: 1) the fractional blood volume of the lung in the Gabrielsson, et al. [27] study was less than the reported value of Brown, et al. [17] and less than the well-stirred partition coefficient for cotinine in the lung; or 2) cotinine distribution to the lung is actually not flow-limited but rather permeability-limited. In this latter case, the optimized parameter for the lung is clearly only meaningful if the appropriate tissue model structure is used. If a permeability-limitation exists, but a flow-limited model is used to fit pharmacokinetic data, the meaningfulness of the model parameters is questionable. The lung cotinine example demonstrates the potential benefit to using the flow-limited two-subcompartment model along with the well-stirred tank to better understand drug pharmacokinetics through incorporation of more biophysical and physiological detail into PBPK tissue models.

Figure 7. Simulated concentration-time curves for the well-stirred tank and flow-limited two-subcompartment model using well-stirred model-optimized and flow-limited two-subcompartment model-calculated partition coefficients for cotinine.

Figure 7

Lower fractional blood volume tissues (adipose, brain, muscle, splanchnic) and higher fractional blood volume tissues (heart, kidney, liver, lung) are simulated (well-stirred tank, solid light gray lines; flow-limited two-subcompartment, dashed dark gray lines) and plotted against rat pharmacokinetic data from Gabrielsson, et al. [27] (filled dark gray circles, mean; vertical bars, range). The well-stirred model is used to optimize cotinine well-stirred partition coefficients, and cotinine biophysical partition coefficients are calculated from optimized well-stirred partition coefficients based on Eq.18 (Table 4). Plasma concentration-time curves are also plotted in each panel (well-stirred, solid light gray lines; flow-limited two-subcompartment, dashed medium gray lines) against rat plasma time course data (filled light gray squares, mean; vertical bars, range). AUC values are reported in Table 5.

Implication for physiological measurements

The relationship between the biophysical and well-stirred partition coefficients is summarized in Fig. 8. The ratio of λwell-stirred to λbiophys varies between 1 and 1-FBV when λbiophys >1, and the percent difference of λbiophys versus λwell-stirred varies between 0 and 100*FBV when λbiophys >1. For a drug with a biophysical partition coefficient of >1 in the rat lung, where mean fractional blood volume is 0.36 [16], the lowest possible ratio of λwell-stirred to λbiophys is 0.64 and the largest percent difference is 36%. As an example, for diazepam in the rat lung (Table 2, FLT-optimized and WST-optimized partition coefficients), the ratio is 0.73 and the percent difference is 27.4%. However, if the drug partition coefficient is <1, the ratio of λwell-stirred to λbiophys and the absolute percent difference can become very large.

Figure 8. Relationship between the biophysical and well-stirred partition coefficients at a set fractional blood volume.

Figure 8

A,B) The fractional blood volume is arbitrarily set to 0.36 (rat lung). The shaded gray areas indicate the biophysical partition coefficient is <1. A) The ratio of λwell-stirred to λbiophys versus λbiophys. The ratio is always >1 when λbiophys is <1. When λbiophys is >1, the upper and lower dashed lines are the bounds on the ratio of λwell-stirred to λbiophys for a given fraction blood volume (FBV). B) The percent difference between λbiophys and λwell-stirred versus λbiophys. The percent difference is always negative when λbiophys is <1. When λbiophys is >1, the upper and lower dashed lines are the bounds on the percent difference for a given fraction blood volume (FBV).

Since the biophysical and well-stirred partition coefficients are related to each other by tissue fractional blood volume, fractional blood volume takes on newfound importance as a fixed parameter in flow-limited PBPK tissue models, whereby previous use of fractional blood volume was largely restricted to permeability-limited two-subcompartment settings. The potential importance of fractional blood volume was noted previously by Khor and Mayersohn [31,32] in correcting partition coefficients for residual blood in the tissues. However, few papers exist which cite Khor and Mayersohn and apply the correction to pharmacokinetic data. In order to meaningfully convert between the biophysical and well-stirred partition coefficients using fractional blood volume, values for fractional blood volume the literature must be carefully selected. The work of Brown, et al. [17] summarizes tissue fractional blood volumes across species and serves as a major reference for permeability-limited modeling. If the flow-limited two-subcompartment model is adopted for use in PBPK, reassessment of available data on fractional blood volume, as well as the methods to accurately determine fractional blood volume in a range of tissues, may be needed. Experimental techniques used to measure the vascular space require use of a substance impermeant to the endothelium with examples including the work of Everett, et al. [25] using erythrocytes tagged with iron-59 and the recent work of Boswell et al. labeling erythrocytes with technetium-99 in mice [33]. Reconsidering the use and measurement of fractional blood volume will also benefit other two-subcompartment models, such as the permeability-limited two-subcompartment intracellular:extracellular model where interstitial fluid volume is required in addition to vascular volume [34,35].

Summary and implications for PBPK modeling research

The development of the flow-limited two-subcompartment model has highlighted the need to clearly distinguish between two partition coefficients for use in PBPK tissue models: 1) a partition coefficient (λbiophys) for tissue:plasma drug partitioning arrived at using in vitro approaches and prediction algorithms or analyzing experimental data with a two-subcompartment model; and 2) a well-stirred partition coefficient (λwell-stirred) for use in analyzing experimental data with the well-stirred tank model. The flow-limited two-subcompartment model shows how the partition coefficients can be interconverted to allow agreement of two-subcompartment and well-stirred tank model simulations. When using in vitro or a priori predicted tissue:plasma partition coefficients with the well-stirred tank model, the partition coefficient (λbiophys) should be converted to λwell-stirred. Though plasma kinetics do not appear to be substantially impacted by choice of partition coefficient for use in the well-stirred tank, simulation of target tissue drug concentration needed for carrying out mechanistic pharmacodynamic and toxicodynamic modeling may be significantly impacted. A potential advantage to implementing a flow-limited two-subcompartment model is that c2 can be estimated, with the potential to influence pharmacokinetic-pharmacodynamic modeling.

The work presented herein clarifies previous findings from Thompson and Beard regarding the well-stirred tank model [2,16]: the well-stirred tank and the flow-limited two-subcompartment model are both appropriate flow-limited PBPK tissue models as long as the correct partition coefficient is used. The development of the flow-limited two-subcompartment model also highlights the need to reconsider the importance of physiological parameters, such as tissue fractional blood volume, that may improve PBPK model predictability and interpretation of drug pharmacokinetics and pharmacodynamics.

Acknowledgments

This work was supported by NIH grant GM094503. MDT is supported by NIH training grant HL007852. The authors thank Dr. Malcolm Rowland (Professor Emeritus, University of Manchester) and Dr. Ivelina Gueorguieva (Eli Lilly and Company, UK) for kindly sharing the diazepam rat dataset. We are also grateful for helpful comments from reviewers.

Contributor Information

Matthew D. Thompson, Biotechnology and Bioengineering Center, Department of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, USA

Daniel A. Beard, Email: beardda@gmail.com, Biotechnology and Bioengineering Center, Department of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, USA

Fan Wu, CFD Research Corporation, Huntsville, Alabama, USA.

Reference List

  • 1.Huang SM, Rowland M. The Role of Physiologically Based Pharmacokinetic Modeling in Regulatory Review. Clin Pharmacol Ther. 2012;91:542–549. doi: 10.1038/clpt.2011.320. [DOI] [PubMed] [Google Scholar]
  • 2.Thompson MD, Beard DA. Development of appropriate equations for physiologically-based pharmacokinetic modeling of permeability-limited and flow-limited transport. J Pharmacokinet Pharmacodyn. 2011;38:405–421. doi: 10.1007/s10928-011-9200-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Sangren WC, Sheppard CW. Mathematical derivation of the exchange of a labeled substance between a liquid flowing in a vessel and an external compartment. Bull Math Biophys. 1953;15:387–394. [Google Scholar]
  • 4.Poulin P, Theil FP. A Priori prediction of tissue: plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery. J Pharm Sci. 2000;89:16–35. doi: 10.1002/(SICI)1520-6017(200001)89:1<16::AID-JPS3>3.0.CO;2-E. [DOI] [PubMed] [Google Scholar]
  • 5.Poulin P, Theil FP. Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition. J Pharm Sci. 2002;91:1358–1370. doi: 10.1002/jps.10128. [DOI] [PubMed] [Google Scholar]
  • 6.Leo A, Hansch C, Elkins D. Partition Coefficients and their uses. Chemical Reviews. 1971;71:525–616. [Google Scholar]
  • 7.Sato A, Nakajima T. A vial-equilibration method to evaluate the drug-metabolizing enzyme activity for volatile hydrocarbons. Toxicol Appl Pharmacol. 1979;47:41–46. doi: 10.1016/0041-008x(79)90069-3. [DOI] [PubMed] [Google Scholar]
  • 8.Andersen ME, Clewell H, III, Krishnan K. Tissue dosimetry, pharmacokinetic modeling, and interspecies scaling factors. Risk Anal. 1995;15:533–537. doi: 10.1111/j.1539-6924.1995.tb00346.x. [DOI] [PubMed] [Google Scholar]
  • 9.Poulin P, Theil FP. Prediction of pharmacokinetics prior to in vivo studies. I. Mechanism-based prediction of volume of distribution. J Pharm Sci. 2002;91:129–156. doi: 10.1002/jps.10005. [DOI] [PubMed] [Google Scholar]
  • 10.Rowland M. Physiologic pharmacokinetic models: relevance, experience, and future trends. Drug Metab Rev. 1984;15:55–74. doi: 10.3109/03602538409015057. [DOI] [PubMed] [Google Scholar]
  • 11.Shen DD. Toxicokinetics. In: Klaassen C, editor. Casarett & Doull’s Toxicology: The Basic Science of Poisons. 7. McGraw-Hill Professional; 2007. [Google Scholar]
  • 12.Isukapalli SS, Roy A, Georgopoulos PG. Physiologically Based Pharmacokinetic Modeling: Inhalation, Ingestion and Dermal Absorption. In: Ette EI, Williams PJ, editors. Pharmacometrics: The Science of Quantitative Pharmacology Wiley-Interscience. 2007. [Google Scholar]
  • 13.Krishnan K, Andersen ME. Physiologically Based Pharmacokinetic Modeling in Toxicology. In: Hayes AW, editor. Principles and Methods of Toxicology. 5. CRC Press; 2007. [Google Scholar]
  • 14.Mirfazaelian A, Kim KB, Anand SS, Kim HJ, Tornero-Velez R, Bruckner JV, Fisher JW. Development of a physiologically based pharmacokinetic model for deltamethrin in the adult male Sprague-Dawley rat. Toxicol Sci. 2006;93:432–442. doi: 10.1093/toxsci/kfl056. [DOI] [PubMed] [Google Scholar]
  • 15.Godin SJ, DeVito MJ, Hughes MF, Ross DG, Scollon EJ, Starr JM, Setzer RW, Conolly RB, Tornero-Velez R. Physiologically based pharmacokinetic modeling of deltamethrin: development of a rat and human diffusion-limited model. Toxicol Sci. 2010;115:330–343. doi: 10.1093/toxsci/kfq051. [DOI] [PubMed] [Google Scholar]
  • 16.Thompson MD, Beard DA. Physiologically-based pharmacokinetic tissue compartment model selection in drug development and risk assessment. J Pharm Sci. 2011;101:424–435. doi: 10.1002/jps.22768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Brown RP, Delp MD, Lindstedt SL, Rhomberg LR, Beliles RP. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol Ind Health. 1997;13:407–484. doi: 10.1177/074823379701300401. [DOI] [PubMed] [Google Scholar]
  • 18.Gueorguieva I, Nestorov IA, Murby S, Gisbert S, Collins B, Dickens K, Duffy J, Hussain Z, Rowland M. Development of a whole body physiologically based model to characterise the pharmacokinetics of benzodiazepines. 1: Estimation of rat tissue-plasma partition ratios. J Pharmacokinet Pharmacodyn. 2004;31:269–298. doi: 10.1023/b:jopa.0000042737.14033.c6. [DOI] [PubMed] [Google Scholar]
  • 19.Gueorguieva I, Nestorov IA, Rowland M. Fuzzy simulation of pharmacokinetic models: case study of whole body physiologically based model of diazepam. J Pharmacokinet Pharmacodyn. 2004;31:185–213. doi: 10.1023/b:jopa.0000039564.35602.78. [DOI] [PubMed] [Google Scholar]
  • 20.Gueorguieva I, Aarons L, Rowland M. Diazepam pharamacokinetics from preclinical to phase I using a Bayesian population physiologically based pharmacokinetic model with informative prior distributions in WinBUGS. J Pharmacokinet Pharmacodyn. 2006;33:571–594. doi: 10.1007/s10928-006-9023-3. [DOI] [PubMed] [Google Scholar]
  • 21.Igari Y, Sugiyama Y, Sawada Y, Iga T, Hanano M. Tissue distribution of 14C-diazepam and its metabolites in rats. Drug Metab Dispos. 1982;10:676–679. [PubMed] [Google Scholar]
  • 22.Igari Y, Sugiyama Y, Sawada Y, Iga T, Hanano M. Prediction of diazepam disposition in the rat and man by a physiologically based pharmacokinetic model. J Pharmacokinet Biopharm. 1983;11:577–593. doi: 10.1007/BF01059058. [DOI] [PubMed] [Google Scholar]
  • 23.Seng KY, Nestorov I, Vicini P. Physiologically based pharmacokinetic modeling of drug disposition in rat and human: a fuzzy arithmetic approach. Pharm Res. 2008;25:1771–1781. doi: 10.1007/s11095-007-9447-5. [DOI] [PubMed] [Google Scholar]
  • 24.Berezhkovskiy LM. Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination. J Pharm Sci. 2004;93:1628–1640. doi: 10.1002/jps.20073. [DOI] [PubMed] [Google Scholar]
  • 25.Everett NB, Simmons B, Lasher EP. Distribution of blood (Fe 59) and plasma (I 131) volumes of rats determined by liquid nitrogen freezing. Circ Res. 1956;4:419–424. doi: 10.1161/01.res.4.4.419. [DOI] [PubMed] [Google Scholar]
  • 26.Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev. 1996;18:188–204. doi: 10.1093/oxfordjournals.epirev.a017925. [DOI] [PubMed] [Google Scholar]
  • 27.Gabrielsson J, Bondesson U. Constant-rate infusion of nicotine and cotinine. I. A physiological pharmacokinetic analysis of the cotinine disposition, and effects on clearance and distribution in the rat. J Pharmacokinet Biopharm. 1987;15:583–599. doi: 10.1007/BF01068414. [DOI] [PubMed] [Google Scholar]
  • 28.Robinson DE, Balter NJ, Schwartz SL. A physiologically based pharmacokinetic model for nicotine and cotinine in man. J Pharmacokinet Biopharm. 1992;20:591–609. doi: 10.1007/BF01064421. [DOI] [PubMed] [Google Scholar]
  • 29.Pubchem Database. National Center for Biotechnology Information; [Accessed 2012]. ( http://www.ncbi.nlm.nih.gov/pccompound) [Google Scholar]
  • 30.Rodgers T, Leahy D, Rowland M. Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases. J Pharm Sci. 2005;94:1259–1276. doi: 10.1002/jps.20322. [DOI] [PubMed] [Google Scholar]
  • 31.Khor SP, Mayersohn M. Potential error in the measurement of tissue to blood distribution coefficients in physiological pharmacokinetic modeling. Residual tissue blood. I. Theoretical considerations. Drug Metab Dispos. 1991;19:478–485. [PubMed] [Google Scholar]
  • 32.Khor SP, Bozigian H, Mayersohn M. Potential error in the measurement of tissue to blood distribution coefficients in physiological pharmacokinetic modeling. Residual tissue blood. II. Distribution of phencyclidine in the rat. Drug Metab Dispos. 1991;19:486–490. [PubMed] [Google Scholar]
  • 33.Boswell CA, Ferl GZ, Mundo EE, Bumbaca D, Schweiger MG, Theil FP, Fielder PJ, Khawli LA. Effects of anti-VEGF on predicted antibody biodistribution: roles of vascular volume, interstitial volume, and blood flow. PLoS One. 2011;6:e17874. doi: 10.1371/journal.pone.0017874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Tsuji A, Yoshikawa T, Nishide K, Minami H, Kimura M, Nakashima E, Terasaki T, Miyamoto E, Nightingale CH, Yamana T. Physiologically based pharmacokinetic model for beta-lactam antibiotics I: Tissue distribution and elimination in rats. J Pharm Sci. 1983;72:1239–1252. doi: 10.1002/jps.2600721103. [DOI] [PubMed] [Google Scholar]
  • 35.Kawai R, Mathew D, Tanaka C, Rowland M. Physiologically based pharmacokinetics of cyclosporine A: extension to tissue distribution kinetics in rats and scale-up to human. J Pharmacol Exp Ther. 1998;287:457–468. [PubMed] [Google Scholar]

RESOURCES